\-\ Texto\\:\\ \ \(0\)\
\-\ unremarkable\ \(371\)\
\-\ mr\\ study\\ vs\\.\\ sulfur\\ colloid\\ study\ \(0\)\
\-\ unenhanced\\ liver\\ ct\\ demonstrates\\ a\\ round\\ lesion\\ in\\ left\\ lobe\\ of\\ liver\\ that\\ is\\ isodense\\ to\\ liver\\ with\\ a\\ central\\ area\\ f\\ decreased\\ attenuation\\.\\ late\\ arterial\\ phase\\ image\\ demonstrates\\ enhancement\\ of\\ the\\ 4\\ cm\\ round\\ lesion\\ with\\ a\\ persistent\\ central\\ 1\\ cm\\ area\\ that\\ did\\ not\\ enhance\\.\\ portal\\ venous\\ phase\\ image\\ demonstrates\\ isoattenuation\\ to\\ liver\\ and\\ persistent\\ hypoattenuation\\ of\\ the\\ central\\ area\\.\ \(0\)\
\-\ this\\ is\\ a\\ differential\\ case\\.\\ final\\ diagnosis\\ is\\ pending\ \(0\)\
\-\ focal\\ nodular\\ hyperplasia\\ \\(most\\ likely\\ based\\ on\\ age\\,\\ gender\\ and\\ appearance\\)\ \(0\)\
\-\ hepatic\\ adenoma\ \(5\)\
\-\ fibrolamellar\\ hepatocellular\\ carcinoma\ \(0\)\
\-\ hemangioma\\ \\(less\\ likely\\)\ \(0\)\
\-\ 31\\ y\\.o\\.\\ female\\,\\ asymptomatic\\ had\\ incidental\\ finding\\ of\\ a\\ \\"hepatic\\"\\ lesion\\ in\\ a\\ ct\\ study\\ performed\\ in\\ korea\\.\\ patient\\ does\\ not\\ have\\ previous\\ study\\ and\\ a\\ repeat\\ ct\\ was\\ requested\\ at\\ a\\ dod\\ medical\\ facility\\.\\ patient\\ is\\ otherwise\\ in\\ good\\ health\\.\ \(0\)\
\-\ this\\ patient\\ was\\ lost\\ to\\ follow\\-up\\ and\\ will\\ remain\\ a\\ differential\\ case\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ liver\\:\\ 0\\.27680208579668736\ \(0\)\
\-\ study\\:\\ 0\\.26760608448922746\ \(0\)\
\-\ central\\:\\ 0\\.2009638066867331\ \(0\)\
\-\ area\\:\\ 0\\.19495257366141372\ \(0\)\
\-\ phase\\:\\ 0\\.17167451337943526\ \(0\)\
\-\ round\\:\\ 0\\.16438752871032064\ \(0\)\
\-\ korea\\:\\ 0\\.16042227335148915\ \(0\)\
\-\ hepatic\\:\\ 0\\.15976836189131555\ \(0\)\
\-\ persistent\\:\\ 0\\.15457945099366852\ \(0\)\
\-\ isoattenuation\\:\\ 0\\.15329204651252082\ \(0\)\
\-\ dod\\:\\ 0\\.15329204651252082\ \(0\)\
\-\ demonstrates\\:\\ 0\\.15118843229583967\ \(0\)\
\-\ lesion\\:\\ 0\\.14427680454487044\ \(0\)\
\-\ hypoattenuation\\:\\ 0\\.1304437613713266\ \(0\)\
\-\ differential\\:\\ 0\\.1303570118789299\ \(0\)\
\-\ image\\:\\ 0\\.12830765905288047\ \(0\)\
\-\ sulfur\\:\\ 0\\.12385466347814837\ \(0\)\
\-\ fibrolamellar\\:\\ 0\\.12385466347814837\ \(0\)\
\-\ likely\\:\\ 0\\.11988909980583742\ \(0\)\
\-\ gender\\:\\ 0\\.11747286036027638\ \(0\)\
\-\ cm\\:\\ 0\\.11522175039971994\ \(0\)\
\-\ ct\\:\\ 0\\.11457026572536531\ \(0\)\
\-\ isodense\\:\\ 0\\.11222377067121224\ \(0\)\
\-\ is\\:\\ 0\\.1098855507913683\ \(0\)\
\-\ unenhanced\\:\\ 0\\.10959420980021167\ \(0\)\
\-\ colloid\\:\\ 0\\.1049054639309508\ \(0\)\
\-\ requested\\:\\ 0\\.1049054639309508\ \(0\)\
\-\ lost\\:\\ 0\\.1049054639309508\ \(0\)\
\-\ hepatocellular\\:\\ 0\\.1031276580694427\ \(0\)\
\-\ remain\\:\\ 0\\.10151319448524226\ \(0\)\
\-\ case\\:\\ 0\\.10079228819722645\ \(0\)\
\-\ in\\:\\ 0\\.09981844305797787\ \(0\)\
\-\ facility\\:\\ 0\\.09947625689592118\ \(0\)\
\-\ health\\:\\ 0\\.09920361107573973\ \(0\)\
\-\ final\\:\\ 0\\.09841015454350241\ \(0\)\
\-\ patient\\:\\ 0\\.09788031758315482\ \(0\)\
\-\ portal\\:\\ 0\\.09599743123047436\ \(0\)\
\-\ late\\:\\ 0\\.09469422007502512\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.09145318332411426\ \(0\)\
\-\ enhance\\:\\ 0\\.08979296040329361\ \(0\)\
\-\ 31\\:\\ 0\\.08901815212639927\ \(0\)\
\-\ repeat\\:\\ 0\\.08798775598551782\ \(0\)\
\-\ that\\:\\ 0\\.08706413207151976\ \(0\)\
\-\ hemangioma\\:\\ 0\\.08438108977160927\ \(0\)\
\-\ and\\:\\ 0\\.08291378649011816\ \(0\)\
\-\ arterial\\:\\ 0\\.08261000398016846\ \(0\)\
\-\ pending\\:\\ 0\\.08250501678391152\ \(0\)\
\-\ good\\:\\ 0\\.08158731449479294\ \(0\)\
\-\ adenoma\\:\\ 0\\.07997459401443895\ \(0\)\
\-\ nodular\\:\\ 0\\.07988418094565777\ \(0\)\
\-\ not\\:\\ 0\\.07920234680789569\ \(0\)\
\-\ of\\:\\ 0\\.07852321499360068\ \(0\)\
\-\ attenuation\\:\\ 0\\.07675331300625288\ \(0\)\
\-\ vs\\:\\ 0\\.07652833804264769\ \(0\)\
\-\ previous\\:\\ 0\\.07579855269440423\ \(0\)\
\-\ to\\:\\ 0\\.07523413454791297\ \(0\)\
\-\ incidental\\:\\ 0\\.07435801526341086\ \(0\)\
\-\ based\\:\\ 0\\.07266400351087021\ \(0\)\
\-\ did\\:\\ 0\\.0719604975744521\ \(0\)\
\-\ venous\\:\\ 0\\.07161902464824717\ \(0\)\
\-\ otherwise\\:\\ 0\\.07150665811167382\ \(0\)\
\-\ was\\:\\ 0\\.06992012469072646\ \(0\)\
\-\ does\\:\\ 0\\.06934850523808979\ \(0\)\
\-\ this\\:\\ 0\\.06893868429578989\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.0682911467176936\ \(0\)\
\-\ less\\:\\ 0\\.06824456310597482\ \(0\)\
\-\ unremarkable\\:\\ 0\\.06724975632628807\ \(0\)\
\-\ finding\\:\\ 0\\.06593712699522829\ \(0\)\
\-\ mr\\:\\ 0\\.06490706257428348\ \(0\)\
\-\ will\\:\\ 0\\.06456410971513928\ \(0\)\
\-\ medical\\:\\ 0\\.06375290369551016\ \(0\)\
\-\ age\\:\\ 0\\.0629774741286039\ \(0\)\
\-\ decreased\\:\\ 0\\.0621359114890981\ \(0\)\
\-\ appearance\\:\\ 0\\.060474800219756625\ \(0\)\
\-\ focal\\:\\ 0\\.06000268318938208\ \(0\)\
\-\ carcinoma\\:\\ 0\\.06000268318938208\ \(0\)\
\-\ performed\\:\\ 0\\.059345479213966094\ \(0\)\
\-\ lobe\\:\\ 0\\.05797029536675231\ \(0\)\
\-\ enhancement\\:\\ 0\\.057738397898939385\ \(0\)\
\-\ most\\:\\ 0\\.052205905947384425\ \(0\)\
\-\ diagnosis\\:\\ 0\\.05200153139712031\ \(0\)\
\-\ have\\:\\ 0\\.050111829628446784\ \(0\)\
\-\ had\\:\\ 0\\.049979608681183674\ \(0\)\
\-\ female\\:\\ 0\\.04840563359363232\ \(0\)\
\-\ the\\:\\ 0\\.04003214367744572\ \(0\)\
\-\ with\\:\\ 0\\.03928506629792416\ \(0\)\
\-\ at\\:\\ 0\\.037889477782483805\ \(0\)\
\-\ left\\:\\ 0\\.03421894106656393\ \(0\)\
\-\ on\\:\\ 0\\.03029623805261938\ \(0\)\
